Top Markets
Coin of the day
Ceryvyn Therapeutics Ltd Ceryvyn Therapeutics Ltd

Ceryvyn Therapeutics Ltd

OPT
Rangering i aksjer #32061
Opthea Limited is an Australian clinical-stage biopharmaceutical company... Opthea Limited is an Australian clinical-stage biopharmaceutical company focused on developing and commercializing therapies primarily for eye diseases. The foundation of its development efforts lies in its intellectual property portfolio, which targets Vascular Endothelial Growth Factors (VEGF-C, VEGF-D, and VEGF Receptor-3). This technology is designed to address conditions linked to the growth of blood and lymphatic vessels, as well as vascular leakage. The company's leading asset, OPT 302, is a soluble form of VEGFR3 currently undergoing clinical trials. This novel therapy aims to treat wet neovascular age-related macular degeneration (wet AMD) and diabetic macular edema (DME). OPT 302 is distinguished as a first-in-class VEGF-C/D inhibitor, intended to be used in conjunction with VEGF-A inhibitors for the treatment of wet AMD and various other retinal diseases. Originally incorporated in 1984 as Circadian Technologies Limited, the company rebranded to Opthea Limited in December 2015 and is headquartered in South Yarra, Australia.
Aksjekurs
$0.00846342
Sist synkronisert: 2026-07-27
Markedsverdi
$11.27M
Endring (1 dag)
0.00%
Endring (1 år)
-97.73%
Land
AU
Handel Ceryvyn Therapeutics Ltd (OPT)

Kategori

Aksjeprishistorikk for Ceryvyn Therapeutics Ltd (OPT)
Høyeste sluttskurs: $0.01 den 2026-07-01

Laveste sluttskurs: $0.15 den 1988-01-01
Aksjeprishistorikk for Ceryvyn Therapeutics Ltd fra 1988 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -97.42%
2025 -17.38%
2024 36.42%
2023 -47.47%
2022 -29.76%
2021 -42.95%
2020 -21.82%
2019 392.18%
2018 -26.17%
2017 3.79%
2016 123.11%
2015 83.08%
2014 -28.91%
2013 -50.84%
2012 -18.93%
2011 -21.00%
2010 -4.21%
2009 56.43%
2008 -61.92%
2007 -15.72%
2006 48.79%
2005 -49.73%
2004 14.79%
2003 76.25%
2002 -45.07%
2001 -20.31%
2000 -3.29%
1999 342.53%
1998 -1.81%
1997 -40.09%
1996 4.15%
1995 17.13%
1994 73.78%
1993 152.67%
1992 175.78%
1991 -30.00%
1990 -46.43%
1989 9.69%
1988 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$112.11 -36.37%
AU
$736.64 6.99%
CH
$1.06K -6.98%
KR